Ambrx Inc.

Ambrx Inc. is a biopharmaceutical company based in La Jolla, Calif. that specializes in developing protein-based drugs using its proprietary ReCODE technology. This technology is used in a variety of protein applications, including cytokines, peptides, and antibodies, and has proven to be beneficial in various therapeutic areas. Ambrx's protein medicinal chemistry combines the power of medicinal chemistry with recombinant biosynthesis, allowing the company to optimize the pharmaceutical properties of lead candidate proteins. Additionally, Ambrx owns and controls a comprehensive intellectual property portfolio related to the incorporation of nonnative amino acids into biosynthetic proteins and is an exclusive commercial licensee under the intellectual property rights owned by The Scripps Research Institute.